Ratings by Needham (Ami Fadia)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/7/2026 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2026 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2026 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2026 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2026 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2026 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2026 | MapLight Therapeutics | MPLT | New Coverage | Buy (N/A) |
24.14 (28.34) |
17.4% | Details | |
| 3/31/2026 | Centessa Pharmaceuticals | CNTA | Downgrade | Hold (Buy) |
27.58 (39.85) |
44.49% | Details | |
| 3/18/2026 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2026 | Day One Biopharmaceuticals | DAWN | Downgrade | Hold (Buy) |
12.78 (21.53) |
68.47% | Details | |
| 3/6/2026 | GH Research PLC | GHRS | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/4/2026 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 1/12/2026 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | GH Research PLC | GHRS | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2026 | MindMed | MNMD | Maintain | Hold (N/A) |
|
Details | ||
| 12/31/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2025 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2025 | Alkermes | ALKS | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2025 | Neumora Therapeutics | NMRA | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2025 | Avadel Pharmaceuticals | AVDL | Downgrade | Hold (Buy) |
17.87 (21.64) |
21.1% | Details | |
| 10/13/2025 | GH Research PLC | GHRS | New Coverage | Buy (N/A) |
12.59 (24.43) |
94.04% | Details | |
| 10/13/2025 | atai Life Sciences N.V | ATAI | New Coverage | Buy (N/A) |
5.10 (4.53) |
-11.18% | Details | |
| 10/13/2025 | MindMed | MNMD | New Coverage | Buy (N/A) |
11.81 (15.02) |
27.18% | Details | |
| 9/29/2025 | Merus N.V. | MRUS | Downgrade | Hold (Buy) |
68.89 (90.00) |
30.64% | Details | |
| 9/22/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 9/15/2025 | Immuneering Corporation | IMRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2025 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2025 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2025 | Blueprint Medicines | BPMC | Downgrade | Hold (Buy) |
101.35 (129.46) |
27.74% | Details | |
| 5/28/2025 | Alkermes | ALKS | New Coverage | Buy (N/A) |
29.90 (42.76) |
43.01% | Details | |
| 5/28/2025 | Centessa Pharmaceuticals | CNTA | New Coverage | Buy (N/A) |
12.77 (27.58) |
115.97% | Details | |
| 5/23/2025 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2025 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2025 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2025 | Neurocrine Bio. | NBIX | Upgrade | Buy (Hold) |
94.89 (165.11) |
74% | Details | |
| 3/3/2025 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2025 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2025 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2025 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2025 | Intra-Cellular Therapies | ITCI | Downgrade | Hold (Buy) |
94.87 (131.87) |
39% | Details | |
| 12/11/2024 | Cogent | COGT | Downgrade | Hold (Buy) |
9.50 (32.26) |
239.58% | Details | |
| 12/6/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2024 | Bicycle Therapeutics | BCYC | Maintain | Buy (Buy) |
|
Details | ||
| 11/18/2024 | Biogen | BIIB | Downgrade | Hold (Buy) |
159.99 (195.96) |
22.48% | Details | |
| 11/13/2024 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2024 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2024 | Revolution | RVMD | Maintain | Buy (Buy) |
|
Details | ||
| 10/9/2024 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2024 | Revolution | RVMD | Maintain | Buy (Buy) |
|
Details | ||
| 9/12/2024 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (Buy) |
|
Details | ||
| 9/4/2024 | Praxis Precision Medicines Inc. | PRAX | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2024 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2024 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2024 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 7/22/2024 | Neumora Therapeutics | NMRA | New Coverage | Buy (N/A) |
11.28 (1.74) |
-84.57% | Details | |
| 7/22/2024 | Axsome Therapeutics | AXSM | New Coverage | Buy (N/A) |
84.85 (233.49) |
175.18% | Details | |
| 7/16/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2024 | Praxis Precision Medicines Inc. | PRAX | New Coverage | Buy (N/A) |
41.70 (278.93) |
568.9% | Details | |
| 5/3/2024 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2024 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2024 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2024 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2024 | Immuneering Corporation | IMRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 3/7/2024 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2024 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2024 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2024 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2024 | Acadia Pharmaceuticals | ACAD | Upgrade | Buy (Hold) |
28.15 (21.43) |
-23.87% | Details | |
| 12/20/2023 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2023 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2023 | Immuneering Corporation | IMRX | New Coverage | Buy (N/A) |
6.56 (4.55) |
-30.64% | Details | |
| 11/9/2023 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2023 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2023 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2023 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2023 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2023 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2023 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Sage Therapeutics | SAGE | Downgrade | Hold (Buy) |
16.75 (8.68) |
-48.18% | Details | |
| 8/4/2023 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2023 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2023 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2023 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 7/14/2023 | Theseus Pharmaceuticals Inc. | THRX | Downgrade | Hold (Buy) |
9.52 (4.06) |
-57.35% | Details | |
| 5/23/2023 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2023 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2023 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2023 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2023 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2023 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2023 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2023 | Day One Biopharmaceuticals | DAWN | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2023 | Cogent | COGT | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2023 | Seagen | SGEN | Downgrade | Hold (Buy) |
172.61 (228.74) |
32.52% | Details | |
| 3/6/2023 | Seagen | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2023 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2023 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Bicycle Therapeutics | BCYC | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2023 | Revolution | RVMD | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2023 | Seagen | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2023 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2023 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2022 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2022 | Day One Biopharmaceuticals | DAWN | New Coverage | Buy (N/A) |
20.10 (12.78) |
-36.42% | Details | |
| 12/14/2022 | Revolution | RVMD | New Coverage | Buy (N/A) |
23.30 (155.99) |
569.48% | Details | |
| 12/14/2022 | Theseus Pharmaceuticals Inc. | THRX | New Coverage | Buy (N/A) |
5.50 (4.06) |
-26.18% | Details | |
| 12/14/2022 | Cogent | COGT | New Coverage | Buy (N/A) |
11.95 (32.26) |
169.96% | Details | |
| 12/14/2022 | Blueprint Medicines | BPMC | New Coverage | Buy (N/A) |
46.60 (129.46) |
177.81% | Details | |
| 12/14/2022 | Mirati Therapeutics | MRTX | New Coverage | Hold (N/A) |
41.97 (58.70) |
39.86% | Details | |
| 11/10/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2022 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2022 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (Buy) |
|
Details | ||
| 6/15/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (N/A) |
|
Details | ||
| 6/6/2022 | Merus N.V. | MRUS | Maintain | Buy (Buy) |
|
Details | ||
| 4/19/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (Hold) |
|
Details | ||
| 4/13/2022 | Intra-Cellular Therapies | ITCI | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Bicycle Therapeutics | BCYC | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (Buy) |
|
Details | ||
| 4/12/2022 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (Buy) |
|
Details | ||
| 4/8/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (Hold) |
|
Details | ||
| 3/29/2022 | Intra-Cellular Therapies | ITCI | Maintain | Buy (Buy) |
|
Details | ||
| 3/28/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (Buy) |
|
Details | ||
| 3/9/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (Hold) |
|
Details | ||
| 3/2/2022 | Jazz Pharmaceuticals | JAZZ | Maintain | Buy (Buy) |
|
Details | ||
| 3/2/2022 | Bicycle Therapeutics | BCYC | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2022 | Intra-Cellular Therapies | ITCI | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Hold (Hold) |
|
Details | ||
| 3/1/2022 | Merus N.V. | MRUS | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2022 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (Buy) |
|
Details | ||
| 2/25/2022 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2022 | Sage Therapeutics | SAGE | Maintain | Buy (Buy) |
|
Details | ||
| 2/22/2022 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (Buy) |
|
Details | ||
| 2/16/2022 | Sage Therapeutics | SAGE | Maintain | Buy (Buy) |
|
Details | ||
| 2/15/2022 | Seagen | SGEN | Maintain | Buy (Buy) |
|
Details | ||
| 2/14/2022 | Neurocrine Bio. | NBIX | Maintain | Hold (Hold) |
|
Details | ||
| 2/11/2022 | Neurocrine Bio. | NBIX | Maintain | Hold (Hold) |
|
Details | ||
| 2/10/2022 | Biogen | BIIB | Maintain | Buy (Buy) |
|
Details | ||
| 2/10/2022 | Merus N.V. | MRUS | New Coverage | Buy (N/A) |
26.14 (68.89) |
163.54% | Details | |
| 2/4/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2022 | Biogen | BIIB | Maintain | Buy (Buy) |
|
Details | ||
| 1/28/2022 | Biogen | BIIB | Maintain | Buy (Buy) |
|
Details | ||
| 1/18/2022 | Sage Therapeutics | SAGE | Maintain | Buy (Buy) |
|
Details | ||
| 1/13/2022 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (Buy) |
|
Details | ||
| 1/12/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2022 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 1/11/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2022 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2021 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2021 | Bicycle Therapeutics | BCYC | New Coverage | Buy (N/A) |
56.00 (4.20) |
-92.5% | Details | |
| 12/6/2021 | Intra-Cellular Therapies | ITCI | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2021 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2021 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2021 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 10/19/2021 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 10/18/2021 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2021 | Jazz Pharmaceuticals | JAZZ | New Coverage | Buy (N/A) |
129.10 (230.93) |
78.88% | Details | |
| 9/23/2021 | Avadel Pharmaceuticals | AVDL | New Coverage | Buy (N/A) |
8.12 (17.87) |
120.07% | Details | |
| 9/23/2021 | Sage Therapeutics | SAGE | New Coverage | Buy (N/A) |
45.23 (8.68) |
-80.81% | Details | |
| 9/23/2021 | Intra-Cellular Therapies | ITCI | New Coverage | Buy (N/A) |
37.18 (131.87) |
254.68% | Details | |
| 9/23/2021 | Neurocrine Bio. | NBIX | New Coverage | Hold (N/A) |
95.51 (165.11) |
72.87% | Details | |
| 9/23/2021 | Biogen | BIIB | New Coverage | Buy (N/A) |
295.54 (195.96) |
-33.69% | Details | |
| 9/23/2021 | Acadia Pharmaceuticals | ACAD | New Coverage | Hold (N/A) |
17.02 (21.43) |
25.91% | Details | |
| 9/23/2021 | Harmony Biosciences Holdings Inc. | HRMY | New Coverage | Buy (N/A) |
38.61 (32.10) |
-16.86% | Details |
